Amgen to acquire rare diseases drugmaker Chemocentryx for $4bn

By NS Healthcare Staff Writer

05 Aug 22

Amgen will gain access to Tavneos, Chemocentryx’s oral small molecule drug, designed to selectively inhibit the complement component…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Gilead Sciences to acquire UK biotechnology firm MiroBio for $405m

By NS Healthcare Staff Writer

05 Aug 22

Through the acquisition, Gilead will obtain MiroBio’s unique I-ReSToRE drug discovery platform, along with its complete range of…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Allergan Aesthetics gets FDA nod for Juvéderm Volux XC to improve jawline definition

By NS Healthcare Staff Writer

04 Aug 22

Juvéderm Volux XC is said to be the first and only hyaluronic acid (HA) filler to receive US…

PharmaceuticalsRegulation

Poseida, Roche collaborate on allogeneic CAR-T Cell therapies

By NS Healthcare Staff Writer

04 Aug 22

The collaboration will focus on advancing multiple existing and additional next-generation cell therapies against targets in multiple myeloma,…

PharmaceuticalsPartnerships and Licensing Agreements

Caris Life Sciences, Xencor to develop novel XmAb bispecific antibodies

By NS Healthcare Staff Writer

03 Aug 22

Caris Life Sciences and Xencor will jointly research, develop and commercialise XmAb bispecific antibodies directed against novel targets…

PharmaceuticalsPartnerships and Licensing Agreements

Coherus gets FDA approval for Cimerli as interchangeable biosimilar to Lucentis

By NS Healthcare Staff Writer

03 Aug 22

Cimerli has been approved as an interchangeable product with Lucentis for all five indications, which means the drug…

PharmaceuticalsRegulation

Janssen wins FDA nod for Stelara to treat active psoriatic arthritis in children

By NS Healthcare Staff Writer

02 Aug 22

The US health regulator approved Stelara as the first and only biologic targeting both cytokines interleukin (IL)-12 and…

PharmaceuticalsRegulation

Sosei Heptares, AbbVie to develop novel drugs targeting neurological diseases

By NS Healthcare Staff Writer

02 Aug 22

The new strategic collaboration will leverage Sosei Heptares’ StaR technology and SBDD platform and AbbVie’s extensive neuroscience expertise,…

PharmaceuticalsPartnerships and Licensing Agreements

AbbVie gets EC nod for Rinvoq to treat non-radiographic axial spondyloarthritis

By NS Healthcare Staff Writer

01 Aug 22

The EC approval is supported by data from the Phase 3 SELECT-AXIS 2 clinical trial, in which Rinvoq…

PharmaceuticalsRegulation

Moderna to supply additional doses of bivalent Covid-19 booster vaccine to US

By NS Healthcare Staff Writer

01 Aug 22

Under the new agreement with the US government, the biotechnology company will receive up to $1.74bn for 66…

PharmaceuticalsPartnerships and Licensing Agreements